| ERAMET | 13/05/2009 AGM | |
|---|---|---|
| 1 | Approve the parent company's financial statements | For |
| 2 | Approve Consolidated Financial Statements | For |
| 3 | Approval of regulated related-party agreements | Oppose |
| 4 | Approval of the appropriation of income and of the dividend | For |
| 5 | Reappointment of Mr. Harold Martin as Director for a period of 4 years | Oppose |
| 6 | Election of Mr. Jean-Hervé Lorenzi as Director for a period of 4 years | For |
| 7 | 1)Reappointment as Statutory External Auditor of Ernst & Young Audit for a period of 6 years; 2)Elect Auditex as Substitute External Auditor for a period of 6 years | Oppose |
| 8 | 1)Elect BEAS as Substitute External Auditor for a period of 6 years; 2)Reappointment as Statutory External Auditor of Deloitte & Associés for a period of 6 years | Oppose |
| 9 | Approve buy-back of the company shares | Oppose |
| 10 | Approve potential reduction of the company 's capital by cancellation of treasury stocks | For |
| 11 | Global authorization to issue with pre-emptive subscription right shares or other securities giving way to new capital | For |
| 12 | Increase authorized capital by transfer of reserves | For |
| 13 | 1)Global allowance for the issuance of capital related securities without pre-emptive right; 2)Approve issuance by subsidiary companies of securities offering access to the company's capital stock; 3)Approve issues of shares or other capital related securities as a payment for any public offer | Oppose |
| 14 | Delegation to issue shares and capital securities as consideration for contributions in kind made to the company | Oppose |
| 15 | Limit capital increases with or without pre-emption rights | For |
| 16 | Adopt poison-pill style defence: keep active the authorizations to increase share capital under public offer period | Oppose |
| 17 | Approve capital increase for the employees | For |
| 18 | Issue restricted shares for employees and managers | Oppose |
| 19 | Delegation of powers for the completion of formalities | For |